RecruitingNCT06135870

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

Role of Senescent Cells in Uterine Fibroid Pathogenesis


Sponsor

Johns Hopkins University

Enrollment

150 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators are evaluating the role of senescent cells in uterine fibroids.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study (SOUL Study) investigates the role of senescent cells — old or damaged cells that no longer divide but secrete inflammatory signals — in the development of uterine fibroids (benign tumors in the uterus). Researchers will collect tissue samples during routine procedures to better understand what drives fibroid growth. **You may be eligible if...** - You are a woman between the ages of 18 and 55 - You have suspected uterine fibroids - You have been or are sexually active, or have had a pelvic exam using a speculum - You can read, speak, and understand English or Spanish **You may NOT be eligible if...** - You are unwilling to sign the consent form - You are currently pregnant - You have uterine cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Johns Hopkins Hospital

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06135870


Related Trials